A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

October 5, 2021

Study Completion Date

October 5, 2021

Conditions

Non-infectious Uveitis

Interventions

COMBINATION_PRODUCT

EYS606

EYS606 is a DNA plasmid solution administered by electrotransfection into the ciliary muscle

Trial Locations (3)

Texas Retina Associates, Arlington

Houston Eye Associates, Houston

Cleveland Clinic Foundation, Cleveland